医学
溶栓
纤溶剂
内科学
冲程(发动机)
缺血性中风
组织纤溶酶原激活剂
急诊医学
麻醉
急性中风
缺血
心肌梗塞
机械工程
工程类
作者
Werner Hacke,Markku Kaste,Erich Bluhmki,M Brozman,Antoni Dávalos,Donata Guidetti,Vincent Larrue,Kennedy R. Lees,Zakaria Medeghri,Thomas Leung,Dietmar Schneider,Rüdiger von Kummer,Nils Wahlgren,Danilo Toni
标识
DOI:10.1056/nejmoa0804656
摘要
Intravenous thrombolysis with alteplase is the only approved treatment for acute ischemic stroke, but its efficacy and safety when administered more than 3 hours after the onset of symptoms have not been established. We tested the efficacy and safety of alteplase administered between 3 and 4.5 hours after the onset of a stroke.
科研通智能强力驱动
Strongly Powered by AbleSci AI